Human leukocyte antigen (HLA) class I allotypes vary in their ability to present peptides in the absence of
Related News
FDA Awards $1.1M Contract to CUBRC and EpiVax for Validation of New Immunoinformatic Tool for Prospective Immunogenicity Assessment of Peptide Drugs and Their Impurities
PROVIDENCE, R.I., Oct. 22, 2020 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") and CUBRC, Inc. ("CUBRC") announced today that they have been awarded a two-year, $1.1 million...
PR Newswire 2020-10-22Key Element Of Understanding Language Evolved 40 Million Years
New research has found that chimpanzees and marmoset monkeys can understand a fundamental rule in complex language-like constructions, suggesting that some of the cognitive...
IFL Science 2020-10-22Of course you need a control room in your organization! Or don’t you?
The idea of having a control room appeals to a growing number of organizations and industries. Among the unusual suspects are the healthcare and pharmaceutical industries,...
Public Technologies 2020-10-22Autodesk Generative Design Helps Strengthen and Lighten Hyundai Motor’s Futuristic Walking Car
'What happens if you combine a car and a robot?' asked John Suh, Hyundai's founding director of the company's recently announced New Horizons Studio based in Silicon...
Public Technologies 2020-10-21Gilead Announces New Data on Biktarvy® for the Treatment of HIV in Black Americans
- BRAAVE 2020 Study Demonstrates Non-Inferiority of Biktarvy for the Treatment of HIV in Black Americans Who Are Virologically Suppressed, Including Patients With a History...
Public Technologies 2020-10-21IL-36R signaling integrates innate and adaptive immune-mediated protection against enteropathogenic bacteria [Immunology and Inflammation]
Enteropathogenic bacterial infections are a global health issue associated with high mortality, particularly in developing countries....
PNAS 2020-10-22Extracellular cyclic dinucleotides induce polarized responses in barrier epithelial cells by adenosine signaling [Immunology and Inflammation]
Cyclic dinucleotides (CDNs) are secondary messengers used by prokaryotic and eukaryotic cells. In mammalian cells,...
PNAS 2020-10-22